Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN® (incobotulinumtoxinA) for the treatment of post-stroke lower ...
You might have seen those robot-looking red light masks being sold for skincare purposes. You might have thought — looks technological, but does it work? It's not just red light. There are a spectrum ...
Another big win for Lilly this year came when the FDA approved its eczema drug, Ebglyss. The eczema market is more crowded than Alzheimer's disease and weight loss. But what makes Ebglyss a ...